Virtual group program with glucose monitors for uncontrolled type 2 diabetes
Tests group education and peer support with glucose monitors in adults with type 2 diabetes.
Key facts
- Who runs it
- Whole Endo
- Where
- Asheville, United StatesSee the site
- Trial code
- Registry title
- Continuous Glucose Monitoring, Diabetes Education, and Peer Support for Management of Uncontrolled Type 2 Diabetes
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 1 Aug 2025
- Expected to end
- Aug 2028
- Type of study
- Observational
- Treatments tested
- Education, lifestyle counseling, and peer support
- Record updated
- 8 July 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with type 2 diabetes whose blood sugar is not well controlled. They will join virtual group visits and use a continuous glucose monitor.
- Age
- 18 years and older
- Sex
- All sexes can join.
- Disease stage
- Type 2 diabetes with uncontrolled blood sugar (hemoglobin A1c >8% (64 mmol/mol)).
- Biomarker or test result
- Hemoglobin A1c >8% (64 mmol/mol).
Main reasons for not taking part
- Pregnancy
- Use of steroids
- Active cancer treatment
- Terminal illness
- Dementia or mental impairment
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Adults aged 18 years and older
- Diagnosed with type 2 diabetes mellitus Hemoglobin A1c >8% Must have smartphone to connect with continuous glucose monitor
Who cannot take part
- Pregnancy Use of steroids Active cancer treatment Terminal illness Dementia, mental impairment Type 1 diabetes End stage renal disease, on dialysis
Where in United States
- Whole EndoAsheville, United StatesContact: Rashim Gupta, MDTaking people
About the trial
What the trial wants to find out
This research study is investigating whether a diabetes virtual group visit program using a continuous glucose monitor (CGM) can help improve glucose levels and quality of life in individuals with uncontrolled type 2 diabetes. People in the study will join group visits virtually to discuss using CGM, understanding CGM, and other information about ways to bring blood sugars to your goal (nutrition, movement, reducing stress, and techniques to start a new habit).
Treatments tested
- Education, lifestyle counseling, and peer support
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The COMPASS Program: Continuous Monitoring, Peer And Structured Support for Management of Uncontrolled Type 2 Diabetes - A Prospective Single-Arm Study
- Plain-language title
- Virtual group program with glucose monitors for uncontrolled type 2 diabetesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 8 July 2025